MDL nieuws
- Longitudinal Change of Alcohol Use is a Dynamic Contributor to Steatotic Liver Disease Progression
- Reply to the Letter to the Editor: Distinction of Autoimmune Hepatitis from Drug Induced Autoimmune Like Hepatitis: The Answer Lies at the Interface
- Impacts of glucagon?like peptide?1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction?associated steatotic liver disease cirrhosis and type 2 diabetes
- Implantica completes human factors validation study for RefluxStop as part of the US FDA premarket approval process
- Hepatic Encephalopathy
- Future Therapies of Hepatic Encephalopathy
- Is acute necrotising pancreatitis a chronic disease?
- Endoscopic treatment for early duodenal papillary carcinoma: long?term outcomes
- The impact of lung transplantation on esophageal motility and inter?relationships with reflux and lung mechanics in patients with restrictive and obstructive respiratory disease
- Effect of esophageal body recoil on clinical outcomes in non?spastic achalasia
- Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B—Author's reply
- Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B
- Esophageal body adaptation to Nissen fundoplication: Increased esophagogastric outflow resistance yields delayed and sustained peristaltic contractions without increased amplitude
- Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway
- Do we perceive sensations inside and outside of our body differently? Perceptual, emotional, and behavioral differences between visceral and somatic sensation, discomfort, and pain